lomitapide mesylate

FDA Drug Profile — Juxtapid

lomitapide mesylate is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including Juxtapid. Available dosage form: capsule.

Drug details

Generic Name
lomitapide mesylate
Brand Names
Juxtapid
Application Number
NDA203858
Sponsor
Pharma Packaging Solutions, LLC Dba Tjoapack LLC
NDC Codes
10
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
LOMITAPIDE MESYLATE

Indications and Usage

1 INDICATIONS AND USAGE JUXTAPID is indicated as an adjunct to a low-fat diet and exercise and other low density lipoprotein cholesterol (LDL-C) therapies to reduce LDL-C in adults and pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia (HoFH). JUXTAPID is a microsomal triglyceride transfer protein inhibitor indicated as an adjunct to a low-fat diet and exercise and other low-density lipoprotein cholesterol (LDL-C) therapies, to reduce LDL-C in adult and pediatric patients aged 2 years and older with HoFH. ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.